This inventor holds 1 USPTO granted patent. Top assignee: Kineta, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Thierry Guillaudeux: Inventor in Cancer Immunotherapy
Introduction
Thierry Guillaudeux is an inventor associated with Seattle, Washington, and Kineta, Inc. His patent work concerns antibodies targeting V-domain Ig-containing Suppressor of T cell Activation (VISTA), an immune-regulatory protein.
Latest Patents
Guillaudeux is named on one patent: “Anti-vista antibodies and uses thereof.” The disclosure describes antibodies that bind specifically to VISTA and compositions containing those antibodies. It also outlines potential uses, including methods for treating diseases such as cancer. The patent record provided identifies 1 patent.
Career Highlights
His listed work connects antibody development with cancer treatment research. The patent describes a therapeutic approach aimed at VISTA, with the goal of using targeted antibodies to address disease.
Collaborations
Guillaudeux’s listed coworkers include Shawn P. Iadonato and Eric J. Tarcha. The patent and company information place his work in the context of Kineta, Inc.’s research activities.
Conclusion
Thierry Guillaudeux’s patent contribution focuses on anti-VISTA antibodies and their potential therapeutic applications, including cancer treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile